GAITHERSBURG, Md., April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB...
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold...
Using Voice and AI to Detect Drug & Alcohol Intoxication15 world first discoveries transform our understanding of physiological reactions to...
Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing Delivered 64% gross margin,...
Supporting faster, more consistent end-to-end claim management by embedding decision-support intelligence directly into daily workflows—without replacing human judgmentFORT WORTH, Texas,...
MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader...
Grower trends, F1 hybrids and top breeders shaping the cannabis seed market in 2026 BARCELONA, Spain, April 29, 2026 (GLOBE...
Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to...
CAMBRIDGE, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (Nasdaq: NTLA), a leading biopharmaceutical company focused on revolutionizing...
Total Revenue Increased Led by Higher International Sales Generated Positive Cash Flow and Reiterates Expectation for Full Year Positive Cash...
For an accessible version of this Press Release, please visit www.tevapharm.com Q1 2026 revenues of ~$4.0 billion increased by 2%...
WATERTOWN, Mass., April 29, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative...
Conference Call Scheduled for May 6, 2026, at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., April 29, 2026 (GLOBE...
Robert J. Dempsey, MBA, Chief Executive Officer, to present at EyeceleratorRaj Patil, PhD, Chief Scientific Officer, to present at ARVO...
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will...
SOL-X long-term extension trial in wet AMD enrolled the first subject in April 2026 who had successfully completed the two-year...
Expands DB104 Intellectual Property Portfolio until at least 2043SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Denovo Biopharma, a pioneer...
Company on track to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027,...
Emergent BioSolutions Partners with Professional Baseball Player Davis Schneider to Raise Awareness of NARCAN® Nasal Spray Among Canadians and Help...
Mitapivat (PYRUKYND® and AQVESME™) generated worldwide net revenues of $20.7 million in the first quarter of 2026, compared to $8.7...